Gan & Lee Pharmaceuticals. (SHA:603087)
46.09
-0.31 (-0.67%)
Apr 3, 2025, 2:45 PM CST
SHA:603087 Revenue
Gan & Lee Pharmaceuticals. had revenue of 930.11M CNY in the quarter ending September 30, 2024, with 37.61% growth. This brings the company's revenue in the last twelve months to 2.95B, up 23.78% year-over-year. In the year 2023, Gan & Lee Pharmaceuticals. had annual revenue of 2.61B with 52.31% growth.
Revenue (ttm)
2.95B
Revenue Growth
+23.78%
P/S Ratio
9.27
Revenue / Employee
657.60K
Employees
4,482
Market Cap
27.70B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 2.61B | 895.77M | 52.31% |
Dec 31, 2022 | 1.71B | -1.90B | -52.60% |
Dec 31, 2021 | 3.61B | 250.16M | 7.44% |
Dec 31, 2020 | 3.36B | 466.82M | 16.12% |
Dec 31, 2019 | 2.90B | 507.68M | 21.26% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Jiangsu Hengrui Medicine | 27.98B |
Shenzhen Mindray Bio-Medical Electronics | 37.11B |
WuXi AppTec | 37.92B |
Aier Eye Hospital Group | 20.62B |
Zhangzhou Pientzehuang Pharmaceutical., | 10.91B |
Yunnan Baiyao Group Co.,Ltd | 40.03B |
Shanghai United Imaging Healthcare | 10.30B |
Sichuan Biokin Pharmaceutical | 5.82B |